Manassas, VA (April 15, 2009) — Metabiomics© is now offering the human Genomics research community advanced MultiTag Sequencing™ primers and services including a limited license to use its patent pending MultiTag Sequencing™ method for research purposes. This breakthrough MultiTag Sequencing™ invention relates to multiplex polynucleotide sequence analysis using massively parallel sequencing methods, such as pyrosequencing methods and sequencing by synthesis. The invention provides increased throughput and the ability to analyze greater numbers of samples simultaneously or serially on presently available systems, as well as others yet to be developed. The invention is important for increasing the productivity of DNA analysis of complex microbial communities, particularly to in-depth analysis thereof in large numbers of samples.
@Metabiomics on TwitterMy Tweets
- Origin Sciences and Metabiomics Announce Exclusive Distribution Agreement of OriCol™ Microbiome Sampling Kits in the U.S. December 16, 2015
- Microbiome R&D and Business Collaboration Forum September 10, 2015
- Metabiomics Launches IRB approved Colon Polyp and Colon Cancer Diagnostics Clinical Research Study March 17, 2014
China clinical studies colon cancer test Colorado Capital Conference colorectal cancer colorectal cancer diagnostics Investor conference Kindstar MBAC Metagenomics Microbiome microbiome diagnostics microbiome sampling kit Mid-Atlantic Bio molecular diagnostics MultiTag Sequencing Next-Generation Sequencing OCTANe Medical Device & Investor Forum Oricol Origin Sciences patents Patrick Gillevet Series A